Articles
A midsized pharmaceutical company was developing a treatment targeting newly diagnosed acute myeloid leukemia (AML) patients and selected Covance to support their global Phase III trial. Using LabCorp de-identified clinical laboratory data helped the planning teams locate difficult to find patients and increase recruitment.
Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries.
COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
.png){kind=icon}